+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo



Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo



Journal of Reproductive Medicine 31(11): 1045-1048



A double-blind, parallel study was conducted comparing a new imidazole derivative, butoconazole nitrate, with placebo and miconazole nitrate for the treatment of vulvovaginal candidiasis. Patients were randomly assigned to six treatment regimens. Butoconazole was found to be an effective antifungal agent in both the six- and three-day treatment schedules. The incidence of local side effects from both tested imidazoles was low.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 004863714

Download citation: RISBibTeXText

PMID: 3543342


Related references

Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group. Journal of Reproductive Medicine 44(11): 933-938, 1999

Effect of butoconazole nitrate 2% vaginal cream and miconazole nitrate 2% vaginal cream treatments in patients with vulvovaginal candidiasis. Infectious Diseases in Obstetrics and Gynecology 4(6): 323-328, 1996

A comparison of butoconazole nitrate cream with econazole nitrate cream for the treatment of vulvovaginal candidiasis. Journal of International Medical Research 18(5): 389-399, 1990

Single-dose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis: two single-blind, controlled studies versus miconazole nitrate 100 mg cream for 7 days. Journal of Women's Health and Gender-Based Medicine 9(4): 421-429, 2000

Comparison of terconazole seven day cream versus miconazole nitrate seven day cream in the treatment of vulvovaginal candidiasis. Current Therapeutic Research 49(2): 194-198, 1991

The statement of Polish Gynecological Society Experts on the treatment of acute vulvovaginal candidiasis with prolonged releasing 2% butoconazole nitrate vaginal cream--state of art in 2008. Ginekologia Polska 80(4): 303-311, 2009

An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Infectious Diseases in Obstetrics and Gynecology 13(4): 197-206, 2005

Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis. Journal of Reproductive Medicine 34(7): 479-483, 1989

Monistat cream (miconazole nitrate) a new agent for the treatment of vulvovaginal candidiasis. Journal of Reproductive Medicine 15(3): 123-125, 1975

Evaluation of Monistat cream (miconazole nitrate 2%) in a reduced regimen for the treatment of vulvovaginal candidiasis. Journal of Reproductive Medicine 19(2): 67-69, 1977

Cure rates of oral contraceptive users and non-users when treated for vulvovaginal candidiasis (moniliasis) with miconazole nitrate 2% vaginal cream. Contraception 15(3): 355-361, 1977

Butoconazole vaginal inserts for vulvovaginal candidiasis comparison of clotrimazole. Advances in Therapy 2(2): 60-64, 1985

Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis. Obstetrics and Gynecology 64(4): 530-534, 1984

3 day treatment with butoconazole nitrate for vulvovaginal candidiasis. Obstetrics & Gynecology 64(4): 530-534, 1984

Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis. Journal of Reproductive Medicine 31(2): 131-132, 1986